BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Persico M, Iolascon A. Steatosis as a co-factor in chronic liver diseases. World J Gastroenterol 2010; 16(10): 1171-1176 [PMID: 20222159 DOI: 10.3748/wjg.v16.i10.1171]
URL: https://www.wjgnet.com/1007-9327/full/v16/i10/1171.htm
Number Citing Articles
1
Ignacio Prieto, María Monsalve. ROS homeostasis, a key determinant in liver ischemic-preconditioningRedox Biology 2017; 12: 1020 doi: 10.1016/j.redox.2017.04.036
2
M. Schrader, N.A. Bonekamp, M. Islinger. Fission and proliferation of peroxisomesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012; 1822(9): 1343 doi: 10.1016/j.bbadis.2011.12.014
3
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
4
Chiara Valtolina, Joris H Robben, Robert P Favier, Jan Rothuizen, Guy CM Grinwis, Baukje A Schotanus, Louis C Penning. Immunohistochemical characterisation of the hepatic stem cell niche in feline hepatic lipidosis: a preliminary morphological studyJournal of Feline Medicine and Surgery 2019; 21(2): 165 doi: 10.1177/1098612X18765922
5
Xi-Xi Ni, Min Lian, Hui-Min Wu, Xiao-Yun Li, Li Sheng, Han Bao, Qi Miao, Xiao Xiao, Can-Jie Guo, Hai Li, Xiong Ma, Jing Hua. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseasesWorld Journal of Gastroenterology 2021; 27(1): 80-91 doi: 10.3748/wjg.v27.i1.80
6
Mario Masarone, Marcello Persico. Antiviral therapy: why does it fail in HCV-related chronic hepatitis?Expert Review of Anti-infective Therapy 2011; 9(5): 535 doi: 10.1586/eri.11.10
7
Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Alastair D. Burt. MacSween's Pathology of the Liver2012; : 293 doi: 10.1016/B978-0-7020-3398-8.00006-4
8
Vignan Manne, Sammy Saab. Impact of Nutrition and Obesity on Chronic Liver DiseaseClinics in Liver Disease 2014; 18(1): 205 doi: 10.1016/j.cld.2013.09.008
9
Nishika Sahini, Saravanakumar Selvaraj, Jürgen Borlak, Patricia Aspichueta. Whole Genome Transcript Profiling of Drug Induced Steatosis in Rats Reveals a Gene Signature Predictive of OutcomePLoS ONE 2014; 9(12): e114085 doi: 10.1371/journal.pone.0114085
10
Ali Afsari, Edward Lee, Babak Shokrani, Tina Boortalary, Zaki A. Sherif, Mehdi Nouraie, Adeyinka O. Laiyemo, Kawtar Alkhalloufi, Hassan Brim, Hassan Ashktorab. Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis CDigestive Diseases and Sciences 2017; 62(8): 2159 doi: 10.1007/s10620-017-4626-7
11
Mohamed El-Kassas, Abeer Awad. Metabolic aspects of hepatitis C virusWorld Journal of Gastroenterology 2022; 28(22): 2429-2436 doi: 10.3748/wjg.v28.i22.2429
12
M. Sasso, V. Miette, L. Sandrin, M. Beaugrand. The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®Clinics and Research in Hepatology and Gastroenterology 2012; 36(1): 13 doi: 10.1016/j.clinre.2011.08.001
13
Ki M. Mak, Allison J. Kwong, Edward Chu, Nancy M. Hoo. Hepatic Steatosis, Fibrosis, and Cancer in Elderly CadaversThe Anatomical Record 2012; 295(1): 40 doi: 10.1002/ar.21525
14
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liverOrvosi Hetilap 2015; 156(14): 543 doi: 10.1556/OH.2015.30123
15
Monica Lupsor-Platon, Radu Badea. Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan<sup>&reg;</sup>)World Journal of Gastroenterology 2015; 21(42): 11914-11923 doi: 10.3748/wjg.v21.i42.11914
16
Silvia I. Mora, Jonathan García-Román, Iván Gómez-Ñañez, Rebeca García-Román. Chronic liver diseases and the potential use of S-adenosyl-l-methionine as a hepatoprotectorEuropean Journal of Gastroenterology & Hepatology 2018; 30(8): 893 doi: 10.1097/MEG.0000000000001141
17
Gehan S. Seifeldein, Elham A. Hassan, Hala M. Imam, Rania Makboul, Naglaa K. Idriss, Marwa A. Gaber, Reem M. Elkady. Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosisEgyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00590-2
18
Liana Gheorghe, Speranta Iacob. Essentials of Non-Alcoholic Fatty Liver Disease2023; : 133 doi: 10.1007/978-3-031-33548-8_12
19
Suzanne van Meer, Karel J. van Erpecum, Dave Sprengers, Minneke J. Coenraad, Heinz-Josef Klümpen, Peter L.M. Jansen, Jan N.M. IJzermans, Joanne Verheij, Carin M.J. van Nieuwkerk, Peter D. Siersema, Robert A. de Man. Hepatocellular carcinoma in cirrhotic versus noncirrhotic liversEuropean Journal of Gastroenterology & Hepatology 2016; 28(3): 352 doi: 10.1097/MEG.0000000000000527
20
Ki M. Mak, Dustin Kee, Christopher P. Cheng. A review of hepatic fibrosis‐associated histopathology in aged cadaversThe Anatomical Record 2023; 306(5): 1031 doi: 10.1002/ar.24931
21
Atsushi Takahashi, Teruko Arinaga‐Hino, Hiromasa Ohira, Kazumichi Abe, Takuji Torimura, Mikio Zeniya, Masanori Abe, Kaname Yoshizawa, Akinobu Takaki, Yoshiyuki Suzuki, Jong‐Hon Kang, Nobuhiro Nakamoto, Tomoo Fujisawa, Atsushi Tanaka, Hajime Takikawa. Non‐alcoholic fatty liver disease in patients with autoimmune hepatitisJGH Open 2018; 2(2): 54 doi: 10.1002/jgh3.12046
22
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver2018; : 308 doi: 10.1016/B978-0-7020-6697-9.00005-4
23
K. R. Dudina, P. A. Belyy, I. V. Maev, N. Kh. Safiullina, E. A. Klimova, S. A. Shutko, O. O. Znoyko, N.  D. Yushchuk. Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral TherapyRussian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 32(5): 31 doi: 10.22416/1382-4376-2022-32-5-31-42
24
Paolo Ricchi, Antonella Meloni, Anna Spasiano, Silvia Costantini, Alessia Pepe, Patrizia Cinque, Aldo Filosa. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non‐transfusion‐dependent thalassaemia patientsBritish Journal of Haematology 2018; 180(5): 721 doi: 10.1111/bjh.15083
25
Marianna Lakatos, Krisztina Hagymási, Gabriella Lengyel. Fatty liver and hepatitis C virus infectionOrvosi Hetilap 2011; 152(38): 1513 doi: 10.1556/OH.2011.29209
26
Scott D. Painter, Inna G. Ovsyannikova, Gregory A. Poland. The weight of obesity on the human immune response to vaccinationVaccine 2015; 33(36): 4422 doi: 10.1016/j.vaccine.2015.06.101
27
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver2024; : 330 doi: 10.1016/B978-0-7020-8228-3.00005-3
28
Jae-Sung Ryu, Minji Lee, Seon Ju Mun, Sin-Hyoung Hong, Ho-Joon Lee, Hyo-Suk Ahn, Kyung-Sook Chung, Gun-Hwa Kim, Myung Jin Son. Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver modelJournal of Biological Engineering 2019; 13(1) doi: 10.1186/s13036-019-0198-8
29
Joseph K. Lim, Mindie H. Nguyen. The Role of Hepatic Steatosis in Chronic Hepatitis B InfectionCurrent Hepatitis Reports 2011; 10(2): 134 doi: 10.1007/s11901-011-0090-6
30
Ana C. Cardoso, Michel Beaugrand, Victor de Ledinghen, Catherine Douvin, Raoul Poupon, Jean-Claude Trinchet, Marianne Ziol, Pierre Bedossa, Patrick Marcellin. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis BAnnals of Hepatology 2015; 14(6): 826 doi: 10.5604/16652681.1171762
31
Erin M. Kelly, Vickie A. Feldstein, Dustin Etheridge, Rebecca Hudock, Marion G. Peters. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis BJournal of Ultrasound in Medicine 2017; 36(5): 925 doi: 10.7863/ultra.16.04076